Biocon Pharma Inc. recalled 88,008 bottles of Prazosin Hydrochloride capsules, 1 mg, 100-count bottles, nationwide in the United States. A cGMP deviation detected N-nitroso-prazosin impurity C above acceptable limits. Consumers and healthcare providers should stop using this product immediately and contact Appco Pharma LLC or a healthcare provider for guidance.
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
Consumers and healthcare providers should stop using this product immediately. Contact Appco Pharma LLC or your healthcare provider for guidance. Notification method: E-Mail
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Prazosin Hydrochloride is an antihypertensive prescription medication used to treat high blood pressure and other conditions. The recalled lots are 1 mg, 100-count capsules distributed nationwide in the United States.
The recall is due to a cGMP deviation that detected N-nitroso-prazosin impurity C above acceptable limits in the drug substance.
This recall is not stated as part of a broader industry pattern.
Patients taking these capsules could be exposed to the impurity. Immediate stop-use is advised, and guidance from a healthcare provider is recommended to discuss alternatives.
Refer to the FDA recall page and the recall email notification from Appco Pharma LLC for official instructions.
Refunds or replacements, if offered, typically take several weeks after the company processes the recall.
Keep the recall notice, email communications, and any correspondence with healthcare providers. Document batch/Lot numbers and dates of purchase.
NDC: 70377-066-11. Product: Prazosin Hydrochloride capsules, USP 1 mg, 100-count bottle (Rx Only). Sold nationwide in the USA. Recall date: 2026-03-27. Quantity: 88,008 bottles. Manufactured for: Biocon Pharma Inc., Iselin, NJ. Manufactured by: Appco Pharma LLC, Piscataway, NJ. Lot numbers and expirations: 2404160C (Exp. 2026-03), 2406253C (Exp. 2026-05), 2407311C (Exp. 2026-07), 2407312C (Exp. 2026-07), 2408350C (Exp. 2026-07), 2505172C (Exp. 2027-05), 2506191C (Exp. 2027-06). Distribution: USA nationwide.
No injuries or incidents have been reported.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.
Mazda North American Operations recalls 2025 Mazda CX-70 plug-in hybrids as software issues in the inverter may cause the malfunction indicator lights to illuminate and a loss of drive power in EV mode. Dealers will update inverter software at no cost. Letters were mailed December 19, 2024.
Mazda North American Operations recalls certain 2024-2025 CX-90 and 2025 CX-70 vehicles with a Dash ESU due to startup function failures. Software reprogramming will remedy the issue at no charge. Owner notices were mailed December 18, 2024. Contact Mazda at 1-800-222-5500 Option 6. NHTSA ID 24V814000.
Subaru recalls 2025 Forester vehicles due to potentially loose child seat anchor bolts. Dealers will inspect and tighten bolts at no charge. Owner letters are expected August 15, 2025. Contact Subaru at 1-844-373-6614. Recall number WRC-25.
Nissan recalls 2025 Pathfinder, Murano and INFINITI QX60 for front brake caliper weakness that could fail. Dealers will inspect and replace calipers as needed, free of charge. Letters sent May 9, 2025. Contact Nissan or INFINITI for remedies.
Mazda North American Operations is recalling 2025 CX-50 Hybrid and CX-50 SUVs sold through Mazda dealers. Incorrectly configured restraint-control software may cause the air bag to deploy improperly. Owner notification letters are expected to be mailed August 17, 2025.
Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.
BMW recalls 2025-2026 X1 and X2 models plus MINI Cooper and Countryman variants for front seat belt retractors with damaged torsion bars. The defect may fail to restrain occupants in a crash. Dealers will replace both front retractors at no cost. Owner letters begin November 7, 2025. VIN lookup will be available on NHTSA.gov the same day.